Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of malignant pleural effusions.

Rachel Bennett1, Nick Maskell

  • 1Department of Respiratory Medicine, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Current Opinion in Pulmonary Medicine
|June 2, 2005
PubMed
Summary

Recent advancements in managing malignant pleural effusions include safer talc pleurodesis agents and promising chemotherapy for mesothelioma. Novel agents like transforming growth factor-beta show potential for effective, side-effect-free pleurodesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS).

BMJ open respiratory research·2026
Same author

Outcomes Among Women Using Low-dose Aspirin and Undergoing Euploid, Autologous, Programmed Frozen Embryo Transfer Cycles: A Retrospective Cohort Study.

Journal of human reproductive sciences·2026
Same author

Medical thoracoscopy with talc poudrage and indwelling pleural catheter insertion versus medical thoracoscopy with talc poudrage alone for patients with symptomatic malignant pleural effusion (TACTIC): a randomised, controlled phase 3 trial.

The Lancet. Respiratory medicine·2026
Same author

Acute coronary syndrome after an infective exacerbation of COPD: a prospective cohort study of acute lower respiratory tract disease in hospitalised adults.

ERJ open research·2025
Same author

Characteristics and predictors of clinical outcome in patients with pleural effusions caused by heart, liver and renal failure: results from the ERS International Multicentre Pleural Research Collaborative (IMPACT) registry.

ERJ open research·2025
Same author

Determinants of respiratory tract aerosol generation in a diverse clinical population: an observational study.

BMJ open respiratory research·2025

Area of Science:

  • Pulmonology
  • Oncology
  • Medical Research

Background:

  • Malignant pleural effusions are common, yet optimal management strategies require further research.
  • Current pleurodesis agents, like talc, have efficacy but carry risks, including acute respiratory distress syndrome.
  • Mesothelioma treatment has seen limited progress, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To review recent developments in the management of malignant pleural effusions.
  • To highlight advancements in pleurodesis agents and chemotherapy for malignant effusions and mesothelioma.

Main Methods:

  • Review of recent clinical trials and scientific literature on malignant pleural effusions.
  • Analysis of data on talc pleurodesis, novel pleurodesis agents, and mesothelioma chemotherapy.

Related Experiment Videos

Main Results:

  • Talc remains effective for pleurodesis, with calibrated talc particles reducing morbidity.
  • Novel agents like transforming growth factor-beta show promise in animal models for pleurodesis without side effects.
  • Chemotherapy regimens (pemetrexed/cisplatin, raltitrexed/cisplatin) offer a survival advantage for mesothelioma.

Conclusions:

  • Safer pleurodesis agents represent a significant development in managing malignant effusions.
  • Emerging combination chemotherapy agents hold promise for improved mesothelioma treatment outcomes.